High demand causes mumps vaccine shortage in Japan; OncoQCR's breast cancer vax succeeds in nonhuman primates;

> Higher-than-expected demand for the mumps vaccine has caused a shortage in Japan, though the shortfall is expected to be alleviated between next week and the end of November. Story

> OncoQCR's breast cancer vaccine candidate, OQR200, induced high levels of antibodies and T-cell responses to HER2/neu cancer cells in a nonhuman primate study. Release

Suggested Articles

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.

Takeda has spent considerable resources on its phase 3 dengue vaccine, and now data show the shot was 80% effective in preventing dengue.